Rekvina Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Rekvina Laboratories Ltd. on BSE

Search Inside the pdf :

Rekvina Laboratories Ltd.

19 Jun 2025, 01:15PM

Company Update

Rekvina Laboratories Ltd - 526075 - Clarification On Submission Of Financial Results For The Year Ended …

BSE India

We would like to clarify that the results submitted were audited and were inadvertently marked as unaudited due to clerical error. while uploading however the XBRL was correctly marked as audited and there is no change in financial data submitted across any format . kindly consider the submitted results as Audited standalone Financial results for the financial year ended March 31, 2025.

pdf

Rekvina Laboratories Ltd.

30 May 2025

Result

Rekvina Laboratories Ltd - 526075 - FINANCIAL RESULTS FOR 4TH QTR AND YEAR ENEDED 31.03.2025

BSE India

FINANCIAL RESULTS FOR 4TH QTR AND YEAR ENDED 31.03.2025

pdf

	Mar 2025	Dec 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	0.00	0.00	-	-
Operating Profit Qtr	-0.04	-0.02	-100.0%	-
Net Profit Qtr	-0.04	-0.02	-100.0%	-
Earning Per Share Adjusted latest Qtr	-0.07	-0.04	-75.0%	-

* Standalone data

Detailed Results

Rekvina Laboratories Ltd.

30 May 2025

Board Meeting

Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for OUTCOME OF BOARD MEETING

BSE India

OUTCOME OF BOARD MEETING

pdf

Rekvina Laboratories Ltd.

26 May 2025

SAST

Rekvina Laboratories Ltd - 526075 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niravbhai Jashubhai Patel

pdf

Rekvina Laboratories Ltd.

19 May 2025, 12:48PM

Board Meeting

Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Meeting To Be Held On 30Th …

BSE India

Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone Financial Results of the Company under Indian Accounting Standards (Ind AS) for the Year ended on 31st March 2025 and any other agendas as may be considered necessary with the permission of the chair.

pdf

Rekvina Laboratories Ltd.

08 May 2025

Company Update

Rekvina Laboratories Ltd - 526075 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

This is to inform you that Annual Secretarial Compliance Report under Section 24 (A) of SEBI (LODR), 2015 is not applicable to our company.

pdf

Rekvina Laboratories Ltd.

07 Apr 2025

Company Update

Rekvina Laboratories Ltd - 526075 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate Under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018.

pdf

Rekvina Laboratories Ltd.

27 Mar 2025

SAST

Rekvina Laboratories Ltd - 526075 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Niravbhai Jashubhai Patel

pdf

Rekvina Laboratories Ltd.

26 Mar 2025

SAST

Rekvina Laboratories Ltd - 526075 - Closure of Trading Window

BSE India

Trading window for dealing in securities of the Company by Designated persons and their immediate relatives will remain closed w.e.f April 01, 2025 untill 48 hours after the declaration of Audited Financial Results by the Company for the Quarter and Year ended on March 31, 2025.

pdf

Rekvina Laboratories Ltd.

21 Feb 2025

SAST

REKVINA LABORATORIES LTD. - 526075 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011

BSE India

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dilsan Pharma Impex Pvt Ltd

pdf

Is Rekvina Laboratories Ltd. worth buying?

8 Votes:

Buy 75.0%

Hold 25.0%